MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3
MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare.
- MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare.
- We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION process.
- We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts.
- MIMEDX has supplied over two million allografts, through both direct and consignment shipments.